nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A fatal case of pneumonia and sepsis caused by sequence type 398 methicillin-susceptible Staphylococcus aureus carrying Pantone-Valentine leukocidin in China
|
Zhang, Lizhong |
|
|
28 |
9 |
p. 1329-1331 |
artikel |
2 |
A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database
|
Ito, Saki |
|
|
28 |
9 |
p. 1266-1272 |
artikel |
3 |
Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant
|
Miyashita, Naoyuki |
|
|
28 |
9 |
p. 1344-1346 |
artikel |
4 |
Disseminated fusariosis with cerebral involvement in a patient with acute myeloid leukemia: Successful outcome with intrathecal –and systemic antifungal treatment
|
Risum, Malene |
|
|
28 |
9 |
p. 1324-1328 |
artikel |
5 |
Disseminated Mycolicibacter arupensis and Mycobacterium avium co-infection in a patient with anti-interferon-γ neutralizing autoantibody-associated immunodeficiency syndrome
|
Hirayama, Kaho |
|
|
28 |
9 |
p. 1336-1339 |
artikel |
6 |
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
|
Kawasuji, Hitoshi |
|
|
28 |
9 |
p. 1273-1278 |
artikel |
7 |
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedizolid and linezolid
|
Mikamo, Hiroshige |
|
|
28 |
9 |
p. 1235-1241 |
artikel |
8 |
Emerging norovirus GII.4 Sydney[P31] causing acute gastroenteritis outbreak in children in Japan, during COVID-19, 2021
|
Pham, Ngan Thi Kim |
|
|
28 |
9 |
p. 1347-1351 |
artikel |
9 |
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study
|
Erdoğan, Atike Pınar |
|
|
28 |
9 |
p. 1310-1316 |
artikel |
10 |
Factors associated with development and persistence of post-COVID conditions: A cross-sectional study
|
Miyazato, Yusuke |
|
|
28 |
9 |
p. 1242-1248 |
artikel |
11 |
Genetic and epidemiological analysis of ESBL-producing Klebsiella pneumoniae in three Japanese university hospitals
|
Oka, Keisuke |
|
|
28 |
9 |
p. 1286-1294 |
artikel |
12 |
How do we reduce acyclovir overuse? Impact of FilmArray meningitis/encephalitis panel tests for pediatric patients
|
Otake, Shogo |
|
|
28 |
9 |
p. 1261-1265 |
artikel |
13 |
Linezolid induced thrombocytopenia in critically ill patients: Risk factors and development of a machine learning-based prediction model
|
Maray, Ivan |
|
|
28 |
9 |
p. 1249-1254 |
artikel |
14 |
Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy
|
Toyoda, Hidenori |
|
|
28 |
9 |
p. 1231-1234 |
artikel |
15 |
Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
|
Okumura, Nobumasa |
|
|
28 |
9 |
p. 1340-1343 |
artikel |
16 |
Performance analysis among multiple fully automated anti-SARS-CoV-2 antibody measurement reagents: A potential indicator for the correlation of protection in the antibody titer
|
Kobayashi, Ryo |
|
|
28 |
9 |
p. 1295-1303 |
artikel |
17 |
Pyogenic spondylitis caused by Streptococcus dysgalactiae subspecies equisimilis in a patient with nasopharyngeal cancer
|
Fujii, Keitaro |
|
|
28 |
9 |
p. 1332-1335 |
artikel |
18 |
Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis
|
Yoshimura, Hideaki |
|
|
28 |
9 |
p. 1317-1323 |
artikel |
19 |
Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection
|
Shiraiwa, Sawako |
|
|
28 |
9 |
p. 1279-1285 |
artikel |
20 |
Stability of benzylpenicillin for continuous intravenous infusions: An isotonic formulation for therapeutic use and a low-dose formulation for clinical trial
|
Batty, Kevin T. |
|
|
28 |
9 |
p. 1225-1230 |
artikel |
21 |
Suboptimal vancomycin levels in critically ill children with sickle cell disease and acute chest syndrome
|
Al-Eyadhy, Ayman |
|
|
28 |
9 |
p. 1304-1309 |
artikel |
22 |
Tolerability, adverse events, and efficacy of treatment for Mycobacterium avium complex pulmonary disease in elderly patients
|
Mori, Yuta |
|
|
28 |
9 |
p. 1255-1260 |
artikel |